Managing Post-operative Pain in Children With Cerebral Palsy Using a Pain Pump
CompletedNot applicableNCT00884650
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine which pain management strategy continuous analgesic pump or orally-should be used in the management of children with cerebral palsy.
Study details
- Official title
- Comparing the Effectiveness of an Anesthetic Continuous-infusion Device to Oral Analgesia in Orthopedic Postoperative Pain Control of Children With Cerebral Palsy
- Conditions
- Interventions
- Drug: oral analgesic
- Drug: intravenous analgesic per pump
- Sponsor
- University of Colorado, Denver
- Start date
- 2005-06
- Primary completion
- 2008-04
- Sex
- All
- Age range
- from 3 Years to 17 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Children with cerebral palsy between 3 and 17 years old. * American Society of Anesthesiologists (ASA) intubation grade I, II or III. * Ability of subject or primary caregivers to give informed consent, to understand what the study entails and to be able to complete the patient Pain Diary during the post-operative period. Subjects should be available for daily telephone follow-up until the data is completed and they should be able to return the completed Pain Diary to the Primary Investigator. * Willingness and understanding of parent or guardian to have their child randomized to receive either the continuous infusion pain pump device or oral analgesics for their child's pain management. * English or Spanish-speaking care parent or guardians who are able to complete the Pain Diary. Exclusion Criteria: * ASA IV or V, * Known allergy or sensitivity to bupivacaine, * Subjects who will have more than the above mentioned procedure performed during their surgical visit, * Subjects with significant kidney or liver disease, * Parents/guardians who are assessed by the PI or co-investigators to be unable or unwilling to complete the study's Pain Diary or behavioral tools, and * Parents/guardians who are unwilling to allow their child to be randomly assigned to receive either the pain pump with oral analgesics or oral medications alone.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00884650